"Chronic pain syndrome"

1,323 resultsPro users have access to +105 Systematic Reviews

Filter Results
          • Pro
          • Pro
          • Pro
          • Pro
          • Pro
          • Pro
                    • Pro

                            Clinical Area Pro

                            Further Refinement
                            User Guide

                            User Guide

                            1
                            2024BMJ Best Practice
                            Chronic pain syndromes Skip to main contentSkip to searchLog inEnglish#{autosuggest.search}#{autosuggest.search}Chronic pain syndromesVer contenido en español MENULog in or subscribe to access all of BMJ Best PracticeLast reviewed:17 Dec 2023Last updated:10 Jan 2024SummaryChronic pain is one of the most common reasons for seeing a primary care physician.Classification of chronic pain may and resolving within 3 months. Chronic pain persists after healing is completed, due to continued activation of neural pain pathways and muscle spasmFrom Marcus DA. Headache and chronic pain syndromes. The case-based guide to targeted assessment and treatment. Totowa, NJ: Humana Press; 2007[Citation ends].History and examKey diagnostic factorspresence of risk factorsduration of pain more than 3 monthsphysical
                            2
                            2018BMJ Best Practice
                            Chronic pain syndromes Chronic pain syndromes - Symptoms, diagnosis and treatment | BMJ Best PracticeSkip to main contentSkip to search * About us * Help * Subscribe * Access through your institution * Log inBMJ Best Practice * Help * Getting started * FAQs * Contact us * Recent updates * Specialties * Calculators * Patient leaflets * Videos * Evidence * Drugs * Recent updates healing and resolving within 3 months. Chronic pain persists after healing is completed, due to continued activation of neural pain pathways and muscle spasmFrom Marcus DA. Headache and chronic pain syndromes. The case-based guide to targeted assessment and treatment. Totowa, NJ: Humana Press; 2007 [Citation ends].History and examKey diagnostic factors * presence of risk factors * duration of pain more
                            Subscribe to Trip PRO for an enhanced experience
                            • Access to millions of Full-text articles where avaliable
                            • Unlock 100,000+ extra articles with Systematic Reviews
                            • Further Filtering Options
                            • No adverts
                            • Advanced Search Ability
                            • Enhanced SmartSearch showing unlimited related articles
                            Read more about Trip PRO
                            3
                            2020Pain Practice
                            Pain Catastrophizing Mediates the Association Between Mindfulness and Psychological Distress in Chronic Pain Syndrome. Trait mindfulness has been found to be inversely associated with emotional distress such as depression and anxiety among patients suffering from pain. The current study investigated the putative mechanisms underlying these associations by examining whether pain catastrophizing
                            4
                            2020Journal of clinical medicine
                            Sub-Perception and Supra-Perception Spinal Cord Stimulation in Chronic Pain Syndrome: A Randomized, Semi-Double-Blind, Crossover, Placebo-Controlled Trial. The introduction of modern sub-perception modalities has improved the efficacy of spinal cord stimulation (SCS) in refractory pain syndromes of the trunk and lower limbs. The objective of this study was to evaluate the effectiveness of low
                            5
                            2020Andrologia
                            Efficacy of testosterone replacement therapy on pain in hypogonadal men with chronic pain syndrome: A subanalysis of a prospective randomised controlled study in Japan (EARTH study). The present study investigated the efficacy of 6 months of testosterone replacement therapy (TRT) on chronic pain syndrome in late-onset hypogonadal (LOH) men. Sixty hypogonadal patients with chronic pain syndrome
                            6
                            Deep brain stimulation for refractory chronic pain syndromes (excluding headache) (IPG382) Overview | Deep brain stimulation for refractory chronic pain syndromes (excluding headache) | Guidance | NICE 1. Home 2. NICE Guidance 3. Conditions and diseases 4. Chronic and neuropathic pain Deep brain stimulation for refractory chronic pain syndromes (excluding headache) Interventional to the NHS in England, Wales, Scotland and Northern Ireland on Deep brain stimulation for refractory chronic pain syndromes (excluding headache).NICE has also published guidance on deep brain stimulation for intractable trigeminal autonomic cephalalgias(NICE interventional procedure guidance 381, March 2011).DescriptionRefractory chronic pain syndromes are characterised by pain that persists despite
                            7
                            [Prolonged paravertebral analgesia in therapy of chronic pain syndrome in critical lower-limb ischaemia]. Chronic pain syndrome in patients presenting with lower-limb critical ischaemia may have considerable significance in progression of the degree of limb ischaemia, and quality of life of patients appears to be largely determined by adequate analgesia. Currently, there is no 'gold standard ' of therapy for chronic pain syndrome in critical lower-limb ischaemia, which makes it necessary to search for new effective and safe methods of analgesia. The purpose of this study was to evaluate efficacy and safety of paravertebral analgesia compared with epidural analgesia in therapy of chronic pain syndrome in critical lower-limb ischaemia. Our prospective randomized double-centre study included
                            8
                            2025PROSPERO
                            Global Usage of Spinal Cord Stimulation Therapy for Chronic Pain Syndrome: A Systematic Review and Meta-Analysis PROSPERO International prospective register of systematic reviews Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms
                            9
                            2025PROSPERO
                            Acute and chronic pain syndromes in patients with MOGAD: systematic review of the main clinical phenotypes and treatment strategies PROSPERO International prospective register of systematic reviews Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant
                            10
                            2025Clinical Trials
                            Neuro-Pain Provides a Dynamic and Interactive Register for the Invasvive Neuromodulatory Therapies for Different Chronic Pain Syndromes. Patients Living in Belgium and Suffering from Persistent Spinal Pain Syndromes Type 2 As Well As Suffering from Compl Patients suffereing from chronic pain due to persistent spinal pain syndromes or complex regional pain syndromes and living in Belgium
                            11
                            2017Anesthesia and Analgesia
                            Alternatives to Opioids in the Pharmacologic Management of Chronic Pain Syndromes: A Narrative Review of Randomized, Controlled, and Blinded Clinical Trials. Chronic pain exerts a tremendous burden on individuals and societies. If one views chronic pain as a single disease entity, then it is the most common and costly medical condition. At present, medical professionals who treat patients to determine effective and mechanism-based treatments for the chronic pain syndromes discussed in this review. Utilization of rigorous and homogeneous research methodology would likely allow for better consistency and reproducibility, which is of utmost importance in guiding evidence-based care.
                            12
                            2024PROSPERO
                            Low dose Naltrexone in the management of chronic pain syndrome : A metanalysis PROSPEROInternational prospective register of systematic reviews Print | PDFLow dose Naltrexone in the management of chronic pain syndrome : A metanalysisAnand Srinivasan, Naveen Hegde, Rituparna Maiti, Debasish HotaTo enable PROSPERO to focus on COVID-19 submissions, this registration record has undergone basic in the management of chronic pain syndrome : A metanalysis. PROSPERO 2024 CRD42024511451 Available from: https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42024511451Review questionWhether Low dose naltrexone is efficacious in ameliorating pain in various chronic pain syndromesSearchesThe search will be conducted in PubMed/MEDLINE advanced search with following MeSH terms and Boolean operators
                            13
                            2024PROSPERO
                            Side Effects associated with Buprenorphine in Patients with Chronic Pain Syndromes: A Systematic Review and Meta-Analysis PROSPERO International prospective register of systematic reviews Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms
                            14
                            2016Clinical Journal of Pain
                            Fibromyalgia and Chronic Pain Syndromes: A White Paper Detailing Current Challenges in the Field. This manuscript, developed by a group of chronic pain researchers and clinicians from around the world, aims to address the state of knowledge about fibromyalgia (FM) and identify ongoing challenges in the field of FM and other chronic pain syndromes that may be characterized by pain centralization potential to use this new knowledge to positively impact their patients' lives. Furthermore, there are persistent misconceptions about FM and a lack of consensus regarding the diagnosis and treatment of FM. This paper presents a framework for future global efforts to improve the understanding and treatment of FM and other associated chronic pain syndromes, disseminate research findings, identify ways
                            15
                            2016Frontiers in neuroscience
                            Potential Mechanisms Supporting the Value of Motor Cortex Stimulation to Treat Chronic Pain Syndromes Throughout the first years of the twenty-first century, neurotechnologies such as motor cortex stimulation (MCS), transcranial magnetic stimulation (TMS), and transcranial direct current stimulation (tDCS) have attracted scientific attention and been considered as potential tools to centrally concerning the establishment of the clinical effectiveness of primary MCS to treat different chronic pain syndromes. Concurrently, the neuromechanisms related to each method of primary motor cortex (M1) modulation have been unveiled. In this respect, the most consistent scientific evidence originates from MCS studies, which indicate the activation of top-down controls driven by M1 stimulation. This concept
                            16
                            2016Pain and therapy
                            Melatonin in Chronic Pain Syndromes Melatonin is a neurohormone secreted by epiphysis and extrapineal structures. It performs several functions including chronobiotic, antioxidant, oncostatic, immune modulating, normothermal, and anxiolytic functions. Melatonin affects the cardiovascular system and gastrointestinal tract, participates in reproduction and metabolism, and body mass regulation is inevitably disordered in chronic pain syndromes, and activation of melatonin adaptive capabilities. On the other hand, there is evidence of melatonin-independent analgesic effect involving melatonin receptors and several neurotransmitter systems.
                            17
                            Clinical characteristics of dry eye patients with chronic pain syndromes. To investigate clinical characteristics of dry eye disease (DED) patients with a chronic pain syndrome. Cross-sectional study. Four hundred twenty-five patients of a tertiary care DED patient cohort in the Netherlands were included. Chronic pain syndromes irritable bowel syndrome, chronic pelvic pain, and fibromyalgia were assessed by questionnaires. Outcome variables were the Ocular Surface Disease Index (OSDI) symptom questionnaire, tear osmolarity, Schirmer test, tear breakup time, conjunctival hyperemia, staining of the cornea and conjunctiva, and amount of mucus. Outcomes were cross-sectionally compared between DED patients with a chronic pain syndrome and those without. A total of 74 out of 425 DED patients (17%) had
                            18
                            2015Pain Practice
                            Traditional Uses of Medicinal Plants from the Canadian Boreal Forest for the Management of Chronic Pain Syndromes. Chronic pain is more prevalent in indigenous populations who often prefer traditional remedies over allopathic drugs. Our objective was to investigate the traditional uses of medicinal plants from the Canadian boreal forest for the management of chronic pain syndromes. We reviewed the most extensive database on medicinal plants used by aboriginal people of the Canadian boreal forest to investigate the plants used in the management of 3 of the most common chronic pain syndromes: arthritis/rheumatism; back pain; and headache/migraine. We also reviewed the pharmacology and phytochemistry literature to investigate concordance with indigenous knowledge. A total of 114 medicinal plant
                            19
                            Neuropathic ocular pain due to dry eye is associated with multiple comorbid chronic pain syndromes Recent data show that dry eye (DE) susceptibility and other chronic pain syndromes (CPS) such as chronic widespread pain, irritable bowel syndrome, and pelvic pain, might share common heritable factors. Previously, we showed that DE patients described more severe symptoms and tended to report
                            20
                            2023PROSPERO
                            Quality of meta-analyses addressing spinal cord stimulation for the treatment of chronic pain syndromes: a systematic review PROSPEROInternational prospective register of systematic reviews Print | PDFQuality of meta-analyses addressing spinal cord stimulation for the treatment of chronic pain syndromes: a systematic reviewDonald Kleppel, Ryan D'Souza, Royce CopelandTo enable PROSPERO to focus D'Souza, Royce Copeland. Quality of meta-analyses addressing spinal cord stimulation for the treatment of chronic pain syndromes: a systematic review. PROSPERO 2023 CRD42023431155 Available from: https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42023431155Review question1. To determine the quality of published meta-analyses assessing pain intensity after spinal cord stimulation